Overview
Holy Name Medical Center is a Primary Stroke Center, as designated by The Joint Commission, the nation's leading healthcare evaluation and accreditation organization. The medical center treats strokes with clot-busting medications when necessary, and/or performs an emergency interventional surgical procedure called a thrombectomy, which removes a potentially damaging or deadly blood clot from a blood vessel in the brain.
Performance Measure
| Thrombolysis in Cerebral Infarction (TICI) – Reperfusion grade of 2a or higher |
YTD 2024 |
| TICI scale is a score that assesses the surgical treatment outcome and evaluates the restoration of blood flow to the brain. The percentage reflects the stroke patients with improved blood flow to their brain following surgical intervention at Holy Name Medical Center. |
100% |
Holy Name Medical Center
Stroke volume and outcomes data are reported publicly per Primary Stroke Center requirements. This data reflects admissions to Holy Name and reported to the AHA/ASA.
| Stroke Type |
2022 Volume |
2023 Volume |
1Q 2024 |
| Ischemic |
205 |
179 |
46 |
| Hemorrhagic |
37 |
20 |
9 |
| Transient Ischemic Attack |
40 |
35 |
10 |
| Total |
282 |
234 |
65 |
| Ischemic Stroke Interventions |
2022 |
2023 |
1Q 2024 |
National Average |
| IV Thrombolytic Rate |
9.8% |
11.1% |
17% |
11.9% |
| Angiogram Complication Rate |
0% |
0% |
0% |
<1% |
